Biotechnological applications of recombinant single-domain antibody fragments

143Citations
Citations of this article
305Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Single-domain antibody fragments possess structural features, such as a small dimension, an elevated stability, and the singularity of recognizing epitopes non-accessible for conventional antibodies that make them interesting for several research and biotechnological applications.Results: The discovery of the single-domain antibody's potentials has stimulated their use in an increasing variety of fields. The rapid accumulation of articles describing new applications and further developments of established approaches has made it, therefore, necessary to update the previous reviews with a new and more complete summary of the topic.Conclusions: Beside the necessary task of updating, this work analyses in detail some applicative aspects of the single-domain antibodies that have been overseen in the past, such as their efficacy in affinity chromatography, as co-crystallization chaperones, protein aggregation controllers, enzyme activity tuners, and the specificities of the unconventional single-domain fragments. © 2011 de Marco; licensee BioMed Central Ltd.

Cite

CITATION STYLE

APA

de Marco, A. (2011, June 9). Biotechnological applications of recombinant single-domain antibody fragments. Microbial Cell Factories. https://doi.org/10.1186/1475-2859-10-44

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free